07.01.2013 Views

NATIONAL INDUSTRIALIZATION CO. (TASNEE) - Bank Audi

NATIONAL INDUSTRIALIZATION CO. (TASNEE) - Bank Audi

NATIONAL INDUSTRIALIZATION CO. (TASNEE) - Bank Audi

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ENTITY OF AUDI SARADAR GROUP<br />

CURRENT PRICE SAR 24.8<br />

FAIR VALUE SAR 33.2<br />

RATING BUY<br />

Stock Data<br />

November 23, 2012<br />

HIGHLIGHTS<br />

Ticker NIC AB<br />

Bloomberg Median TP (SAR) 41.3<br />

Market Cap (SAR mn) 16,589<br />

Market Cap (USD mn) 4,424<br />

Number of Shares (mn) 668.9<br />

Avg Mon Liquidity (SAR mn ) 790.8<br />

52 week High (SAR) 42.3<br />

52 week Low (SAR) 24.8<br />

Ownership Structure<br />

Private Enterprises 38.0%<br />

GOSI 8.6%<br />

Public 53.4%<br />

Tasnee Stock Performance<br />

Bloomberg Consensus<br />

<strong>CO</strong>MPANY <strong>CO</strong>VERAGE<br />

Reine Dagher<br />

Associate<br />

Reine.Dagher@asib.com<br />

Youssef Nizam, CFA<br />

Head of Equity Research<br />

Youssef.Nizam@asib.com<br />

EQUITY RESEARCH<br />

WEAKER-THAN-EXPECTED TiO2 OUTLOOK CUTS FAIR VALUE<br />

FAIR VALUE: REVISED DOWNWARD FROM SAR 46.9/SHARE TO SAR 33.2/SHARE<br />

Tasnee reported net earnings of SAR 417 million for its 3rd quarter of 2012, in line with our estimates<br />

yet representing a major fall on both a Q-o-Q and Y-o-Y basis. The weak performance mainly<br />

stemmed from waning fundamentals in the Titanium Dioxide (TiO2) industry, the largest contributor<br />

to the company’s top line. The continuous destocking in the TiO2 industry and the wait-and-see<br />

approach by consumers resulted in reduced pigment sales volumes for Tasnee and at lower industry<br />

prices. The company’s bottom line was also affected by softer prices in the PolyOlefins (PO) industry,<br />

mainly represented by HDPE, LDPE and PP. In the near-term, weakness in demand fundamentals<br />

is expected to continue in both the TiO2 and PO industry, constituting a threat to Tasnee’s figures.<br />

Long-term, some solidness in industry demand fundamentals should be regained however we do<br />

not expect operating rates and prices to return to peak levels of previous years. Accordingly, with<br />

this bleaker-than-expected economic and industry outlook, we revise downward our target price<br />

from SAR 46.9/share to SAR 33.2/share.<br />

A SOFTER TIO2 INDUSTRY OUTLOOK FOR NEAR-TERM, HOWEVER SHOULD REGAIN<br />

SOME FUNDAMENTAL STRENGTH IN THE LONG-TERM<br />

As TiO2 demand is tightly correlated to economic growth and as signs of sluggish growth in the<br />

economic recovery are resurfacing, the demand outlook for TiO2 remains soft for the near term.<br />

TiO2 prices have dropped by c5% in the 3rd quarter of 2012, primarily on the back of inventory<br />

de-stocking, with prices expected to remain subdued until year-end (especially in light of the<br />

fourth quarter’s seasonality effect). However, looking beyond, TiO2 fundamentals are expected to<br />

regain their solidness gradually, particularly as inventory levels normalize and the global economy<br />

gets back on track. With global GDP forecasts exceeding 4% for the years 2014 through 2017, any<br />

rebound in the US construction market or Chinese infrastructure spending should result in stronger<br />

demand for the white pigment. As such, with an increasing shortage in the titanium feedstock<br />

market and therefore limited supply of TiO2 given limited capacity expansions, a recovery in the<br />

global economy should improve demand and industry prices. However, again we note that any<br />

macro-economic risk to resurface or to linger will threaten global TiO2 demand, thus making it highly<br />

unlikely that operating rates and prices will return to peak levels of previous years.<br />

MAINTAINING OUR BUY RATING IN LIGHT OF A 27% YTD PLUNGE IN STOCK PRICE<br />

We update our investment case on Tasnee, reducing its fair value to SAR 33.2/share. Given the oversold<br />

condition of the stock, witnessing a price plunge of 27% YTD (vs TASI +3.0% YTD) and trading at its 52week<br />

low, the revised target price implies upside potential of 33.9%. Accordingly, we maintain our BUY<br />

rating for investors with a medium to long-term investment horizon.<br />

Despite this negative revision, Tasnee still trades at attractive multiples vis-à-vis global peers<br />

while offering yields materially higher than the industry average. The company trades at 8.6x and<br />

7.8x 2012 and 2013 estimated net earnings, respectively, vs a peer average of 10.9x and 9.7x, for<br />

the same years, respectively. Moreover, Tasnee trades at an EV of 6.5x and 5.7x 2012 and 2013<br />

estimated EBITDA, respectively, vs a peer average of 7.8x and 6.5x, for the same period respectively.<br />

Furthermore, the stock offers a dividend yield of 4.2%, vs a peer average of 3.3%, and a FCF yield of<br />

11.6% vs a peer average of 6.3%. Thus, Tasnee is still regarded as a value and dividend play, despite<br />

this negative revision to our investment case. Moreover, given the long-term growth outlook for<br />

the TiO2 industry and given that Tasnee is the only investment in the MENA region offering TiO2<br />

exposure, holding this stock should allow investors to capitalize on a rebound in the TiO2 market.<br />

FINANCIAL DATA<br />

<strong>CO</strong>MPANY UPDATE<br />

<strong>NATIONAL</strong> <strong>INDUSTRIALIZATION</strong> <strong>CO</strong>. (<strong>TASNEE</strong>)<br />

2011 2012 E 2013 E 2014 E<br />

Sales Revenues (SAR 000) 19,648,743 17,688,114 19,400,399 21,093,501<br />

Net Income (SAR 000) 2,441,423 1,922,880 2,127,952 2,452,397<br />

EPS (SAR) 4.38 2.87 3.18 3.67<br />

DPS (SAR) 2.0 1.0 1.0 2.0<br />

BVPS (SAR) 19.77 17.22 19.08 20.94<br />

PE 7.1 8.6 7.8 6.8<br />

Dividend Yield 4.8% 4.2% 5.1% 7.4%<br />

PB 1.57 1.44 1.30 1.18<br />

1


SAF<strong>CO</strong> <strong>CO</strong>MPANY UPDATE<br />

EQUITY RESEARCH<br />

November 23, 2012<br />

VALUATION<br />

FCFF VALUATION<br />

We revisited our FCFF model incorporating the weaker-than-expected global economic and<br />

industry growth. We reviewed mainly our price projections for TiO2, noting that the latest Cristal<br />

announcement of a TiO2 price increase dated all way back in December 2011. In addition, we<br />

reviewed downward our price projections for HDPE, LDPE and PP. We adjusted our discount rate to<br />

9.0%, from a previous 10.4%, and the growth rate to 2.1%, from a previous 2.4%, to reflect the latest<br />

macro-developments and the latest changes in the company’s financial position. Accordingly, a fair<br />

value of SAR 32.9/share was obtained.<br />

(SAR 000) 2012 E 2013 E 2014 E<br />

Net Income 1,922,880 2,127,952 2,452,397<br />

Change in Working Capital 413,915 (513,935) 834,347<br />

Non-Cash Charges 1,305,363 1,431,728 1,556,677<br />

Capex 1,173,880 1,157,358 1,258,362<br />

Interest Expense 661,848 648,009 577,627<br />

Free Cash Flow to the Firm (FCFF) 2,302,296 3,564,267 2,493,992<br />

Present Value of FCFF 2,302,296 2,997,948 1,923,871<br />

Present Value of Terminal Value 28,517,658<br />

Intrinsic Value of the Firm 35,741,774<br />

Net Debt 13,731,348<br />

Intrinsic Value of Equity 22,010,426<br />

WACC 9.0%<br />

Terminal Growth Rate 2.1%<br />

Shares Outstanding (000) 668,914<br />

NAV per share (SAR) 32.9<br />

SENSITIVITY ANALYSIS<br />

Below is a data table presenting a sensitivity analysis to our price target valuation, assuming various<br />

growth and discount rates.<br />

Terminal Growth Rate<br />

WACC<br />

8.0% 8.5% 9.0% 9.5% 10.0% 10.5% 11.0% 11.5% 12.0%<br />

1.0% 32.8 29.3 26.3 23.6 21.2 19.0 17.1 15.4 13.8<br />

1.25% 34.5 30.8 27.5 24.7 22.2 19.9 17.9 16.0 14.4<br />

1.5% 36.3 32.3 28.9 25.9 23.2 20.8 18.7 16.8 15.0<br />

1.75% 38.3 34.0 30.3 27.1 24.3 21.8 19.6 17.5 15.7<br />

2.0% 40.4 35.8 31.9 28.4 25.4 22.8 20.5 18.4 16.5<br />

2.25% 42.7 37.8 33.5 29.9 26.7 23.9 21.4 19.2 17.2<br />

2.5% 45.2 39.9 35.3 31.4 28.0 25.0 22.4 20.1 18.0<br />

2.75% 48.0 42.1 37.2 33.0 29.4 26.3 23.5 21.1 18.9<br />

3.0% 51.0 44.6 39.3 34.8 30.9 27.6 24.7 22.1 19.8<br />

2


<strong>TASNEE</strong><br />

November 23, 2012<br />

RELATIVE VALUATION<br />

<strong>CO</strong>MPANY UPDATE EQUITY RESEARCH<br />

Using two different earnings multiples, we valued Tasnee on an equal basis with comparable peers<br />

region-wide and world-wide. Tasnee should be trading at a premium to regional counterparts given<br />

mainly its exclusive and significant exposure to TiO2, in addition to its largely diversified income<br />

stream, an advantage shared by very few counterparts in the region. Furthermore, Tasnee should<br />

be trading at a premium to global peers given that the company benefits from a notable feedstock<br />

advantage in the production of polyolefins.<br />

P/E MULTIPLE<br />

Tasnee’s counterparts trade at an average of 10.9x estimated 2012 earnings, opposed to Tasnee trading<br />

at 8.6x its estimated 2012 earnings, implying an unjustified discount to its peers. Based on our 2012<br />

earnings per share (EPS) estimate of SAR 2.87, a fair value of SAR 31.4/share was derived, thus offering<br />

an upside potential of 26.4% for the company’s stock.<br />

EV/EBITDA MULTIPLE<br />

On a forward basis (2012E), Tasnee’s peer group trades at an average EV/EBITDA of 7.8x opposed to<br />

Tasnee’s EV/EBITDA of 6.5x. Accordingly, a fair value of SAR 36.0/share was obtained, resulting in an<br />

upside potential of 45.0%.<br />

(SAR 000)<br />

EBITDA 2012E 5,742,171<br />

Enterprise Value 44,788,933<br />

Net Debt as of YE12 E 13,980,539<br />

Minority Interest as of YE12 E 6,758,963<br />

Market Capitalization 24,049,431<br />

Shares Outstanding (000) 668,914<br />

NAV per Share (SAR) 36.0<br />

FINAL VALUATION<br />

Attributing a 60% weight to the FCFF valuation and the remaining weight to the comparative<br />

valuation, a final fair value of SAR 33.2/share was derived for Tasnee, offering an upside potential of<br />

33.9% (based on the closing price of SAR 24.8/share).<br />

Fair Value (SAR) Weight<br />

FCFF Valuation 32.9 60%<br />

Relative Valuation<br />

P/E 31.4 20%<br />

EV/EBITDA 36.0 20%<br />

Final Fair Value per Share (SAR) 33.2<br />

3


<strong>TASNEE</strong><br />

November 23, 2012<br />

<strong>CO</strong>MPANY UPDATE EQUITY RESEARCH<br />

APPENDIX A: PRO-FORMA IN<strong>CO</strong>ME STATEMENT<br />

(SAR 000) 2011 2012E 2013E 2014E<br />

Sales 19,648,743 17,688,114 19,400,399 21,093,501<br />

Cost of Sales (12,657,082) (11,915,594) (12,784,863) (13,816,243)<br />

Gross Profit 6,991,661 5,772,520 6,615,536 7,277,258<br />

S,G&A expenses (1,597,396) (1,512,215) (1,642,126) (1,785,436)<br />

Share in net income of associates 12,703 16,780 18,952 17,866<br />

Income from operations 5,406,968 4,277,085 4,992,362 5,509,687<br />

Investment income and other 80 159,722 164,481 180,880<br />

Financing charges (692,656) (661,848) (648,009) (577,627)<br />

Income before zakat, income tax and MI 4,713,634 3,774,959 4,508,834 5,112,940<br />

Zakat and income tax on subsidiaries (539,393) (418,342) (527,459) (598,130)<br />

Minority interest (1,725,751) (1,414,213) (1,669,764) (1,893,484)<br />

Income before zakat 2,448,490 1,942,404 2,311,610 2,621,326<br />

Zakat (7,067) (19,524) (183,658) (168,929)<br />

Net Income 2,441,423 1,922,880 2,127,952 2,452,397<br />

APPENDIX B: PRO-FORMA BALANCE SHEET (SUMMARIZED)<br />

(SAR 000) 2011 2012E 2013E 2014E<br />

Cash and cash equivalents 4,636,675 5,140,859 6,349,548 5,285,079<br />

Accounts receivables 4,140,326 3,572,098 3,917,892 4,259,812<br />

Inventories 3,692,544 4,345,280 3,729,822 4,030,715<br />

Prepaid expenses and other assets 391,013 728,451 559,732 540,699<br />

Total current assets 12,860,558 13,786,688 14,556,994 14,116,305<br />

Investments in associated companies and other 471,622 458,969 474,029 489,089<br />

PPE, net 17,830,489 18,388,339 21,415,348 22,193,886<br />

Intangible assets, net 3,569,127 3,390,671 3,212,214 3,033,758<br />

Projects under progress 4,105,038 5,423,000 1,963,000 1,613,000<br />

Other non-current assets 753,256 720,220 746,521 733,370<br />

Total non-current assets 27,067,021 28,929,497 28,405,655 28,634,524<br />

Total Assets 39,927,579 42,716,184 42,962,649 42,750,828<br />

Short-term facilities and Murabaha 3,387,118 1,831,181 2,049,658 2,268,136<br />

Current portion of long-term loans 1,586,773 2,091,846 2,091,846 2,091,846<br />

Accounts payable 1,027,614 1,035,644 1,111,196 900,629<br />

Accrued expenses and other liabilities 1,953,075 1,839,538 1,957,984 2,098,519<br />

Total current liabilities 7,954,580 6,798,210 7,210,685 7,359,130<br />

Long-term loans 11,363,330 15,198,371 13,106,524 11,014,678<br />

Other non-current liabilities 2,833,232 2,441,979 2,391,568 2,152,580<br />

Total non-current liabilities 14,196,562 17,640,350 15,498,092 13,167,258<br />

Total shareholders’ equity 11,022,826 11,518,662 12,764,104 14,005,967<br />

Minority interests 6,753,611 6,758,963 7,489,768 8,218,473<br />

Total Equity 17,776,437 18,277,625 20,253,872 22,224,440<br />

Total Liabilities and Equity 39,927,579 42,716,184 42,962,649 42,750,828<br />

4


<strong>TASNEE</strong><br />

FAIR VALUE DEFINITION<br />

November 23, 2012<br />

RATING GUIDE<br />

ISSUER<br />

<strong>CO</strong>MPANY UPDATE EQUITY RESEARCH<br />

It is an unbiased estimate of the 12-month potential market price of the stock<br />

SELL REDUCE HOLD ACCUMULATE BUY<br />

Downside -30% -10% +10% +30% Upside<br />

BUY: Upside potential in share price is more than 30%<br />

ACCUMULATE: Upside potential in share price is between 10 and 30%<br />

HOLD: Upside or downside potential in share price less than 10%<br />

REDUCE: Downside potential in share price is between 10 and 30%<br />

SELL: Downside potential in share price is more than 30%<br />

<strong>Audi</strong> Saradar Investment <strong>Bank</strong><br />

<strong>Audi</strong> Saradar Investment <strong>Bank</strong> SAL • Lebanese joint stock company with a registered capital of<br />

10,000,000,000 Lebanese Pounds • Commercial Registrar in Beirut: 30812 • Holding number 33 on<br />

the Central <strong>Bank</strong>’s <strong>Bank</strong>s List.<br />

Address: <strong>Bank</strong> <strong>Audi</strong> Plaza • Bab Idriss • Beirut 2021 8102 Lebanon • P.O. Box 11-2560 • Beirut 1107<br />

2808 • Lebanon. Phone: +961 1 964072 • Fax: +961 1 970403 • Email: contactus@asib.com<br />

5


<strong>TASNEE</strong><br />

November 23, 2012<br />

DISCLAIMER<br />

<strong>CO</strong>MPANY UPDATE EQUITY RESEARCH<br />

“All rights reserved. This research document (the “Document”) is prepared by <strong>Audi</strong> Saradar Investment <strong>Bank</strong> SAL (“ASIB”),<br />

being an entity of <strong>Audi</strong> Saradar Group, for the use of the clients of ASIB and/or the clients of any entity within the <strong>Audi</strong><br />

Saradar Group.<br />

This Document is disclosed to you on a confidential basis. Receipt and/or review of this Document constitute your agreement<br />

not to copy, modify, redistribute, retransmit, or disclose to others the contents, opinions, conclusion, or information<br />

contained in this Document prior to public disclosure of the same by ASIB or the <strong>Audi</strong> Saradar Group or without the express<br />

prior written consent of ASIB.<br />

This Document is not intended for dissemination, distribution to, or use by, any person or entity in any country or jurisdiction<br />

which would subject ASIB or any entity within the <strong>Audi</strong> Saradar Group, to any registration or licensing requirements within<br />

these jurisdictions or where it might be considered as unlawful. Accordingly, this Document is for distribution solely in<br />

jurisdictions where permitted and to persons who may receive it without breaching any applicable legal or regulatory<br />

requirements. In any case, this Document shall not be distributed in the Republic of Egypt.<br />

Your attention is drawn to the fact that you should not access this Document if the regulations of your country of citizenship<br />

and/or residency or any applicable regulations prohibit it. In any case, persons who are subject to any restrictions in any<br />

country, such as US persons are not permitted to access information contained herein.<br />

Neither the information, nor any opinion expressed herein constitutes an offer or an invitation or a recommendation to<br />

make an offer, to buy or sell any security or other investment product related to such security or investment. This Document<br />

provides general information only, is not intended to provide personal investment advice or recommendation and does not<br />

take into account the specific investment objectives, financial situation and the particular needs of any specific person who<br />

may receive it. You should seek financial, legal or tax advice regarding the appropriateness and suitability in investing in any<br />

security, other investment or investment strategy discussed or forecasted in this Document.<br />

You should carefully read the definitions of the Rating Guide provided in this Document. In addition you should read this<br />

Document in its entirety and not conclude its contents from the ratings solely.<br />

The information herein was obtained from various public sources believed in good faith to be reliable. Neither ASIB nor any<br />

entity within the <strong>Audi</strong> Saradar Group represents that the information contained in this Document is complete, accurate<br />

or free from any error and makes no representations or warranties whatsoever as to the data, information and opinions<br />

provided herein.<br />

This Document and any information, opinion and prospect contained herein reflect a judgment at its original date<br />

of publication by ASIB and are subject to change without notice. ASIB and/or any entity within the <strong>Audi</strong> Saradar Group<br />

may have issued, and may in the future issue, other research documents that are inconsistent with, and reach different<br />

conclusions from, the information, opinions and prospects presented in this Document.<br />

This Document reflects the different assumptions, views and analytical methods of the analysts who prepared them; ASIB,<br />

and the <strong>Audi</strong> Saradar Group are under no obligation to ensure that such other research documents are brought to the<br />

attention of any recipient of this Document.<br />

ASIB, any entity within the <strong>Audi</strong> Saradar Group, one or more of their affiliates and/or their officers (including but not limited<br />

to their strategists, analysts and sales staff) may have a financial interest in securities of the issuer(s) or related investments,<br />

may engage in securities transactions, on a proprietary basis or otherwise, in a manner inconsistent with the view taken in<br />

this Document and may take a view that is inconsistent with that taken herein.<br />

The price, value of and income from any of the securities or financial instruments mentioned in this Document can fall as well<br />

as rise. The value of securities and financial instruments is subject to market conditions, volatility, exchange rate fluctuation<br />

and credit quality of any issuer that may have a positive or adverse effect on the price or income of such securities or<br />

financial instruments. Any forecasts on the economy, stock market, bond market or the economic trends of the markets are<br />

not necessarily a guide to future returns. You should understand that statements regarding future prospects may not be<br />

realized. Past performance should not be taken as an indication or guarantee of future performance, and no representation<br />

or warranty, express or implied, is made regarding future returns. As a result of the preceding, you may lose, as the case may<br />

be, the amount originally invested.<br />

None of ASIB, any entity within the <strong>Audi</strong> Saradar Group, any of their affiliates and/or their officers (including but not limited<br />

to their strategists, analysts and sales staff) shall be held liable for any loss or damage that may arise, directly or indirectly,<br />

from any use of the information contained in this Document nor for any decision or investment made on the basis of<br />

information contained herein.”<br />

6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!